key: cord-0269490-7zcexrd7
authors: Lam, LK Metthew; Clements, Rebecca L.; Eckart, Kaitlyn A.; Weisman, Ariel R.; Vaughan, Andy E.; Yehya, Nadir; Meyer, Nuala J.; Jurado, Kellie A.; Mangalmurti, Nilam S.
title: Human red blood cells express the RNA sensor TLR7 and bind viral RNA
date: 2022-01-02
journal: bioRxiv
DOI: 10.1101/2022.01.01.474694
sha: 0078443e9be1517b0850223ffc0f262762055fc8
doc_id: 269490
cord_uid: 7zcexrd7

Red blood cells (RBCs) express the nucleic acid-sensing toll-like receptor 9 (TLR9) and bind CpG-containing DNA. However, whether human RBCs express other nucleic acid-sensing TLRs and bind RNA is unknown. Here we show that human RBCs express the RNA sensor, TLR7. TLR7 is present on the red cell membrane and associates with the RBC membrane protein Band 3. RBCs bind synthetic single-stranded RNA and RNA from pathogenic single-stranded RNA viruses. RNA acquisition by RBCs is attenuated by recombinant TLR7 and inhibitory oligonucleotides. Thus, RBCs may represent a previously unrecognized reservoir for RNA, although how RNA-binding by RBCs modulates the immune response has yet to be elucidated. These findings add to the growing list of non-gas exchanging RBC immune functions. Significance Red blood cells interact with pathogens, cytokines, and CpG-containing DNA; however, their immune functions remain largely unexplored. Here, we report that RBCs can bind synthetic or viral RNA and express TLR7. TLR7 interacts with the RBC membrane protein Band 3 and this interaction is increased during acute infection with SARS-CoV-2. Our study suggests that RBCs may have immune functions mediated by viral RNA, and RNA-carrying RBCs can potentially be a reservoir for RNA-based diagnostics.

Despite lacking transcriptional and translational machinery, mature RBCs can exert immune function by binding to inflammatory mediators and pathogens using various receptors. [1] [2] [3] [4] Nucleic-acid sensing is an essential feature of the immune response, critical for triggering downstream inflammation. The nucleic acid-sensing TLRs (TLR3, 7, 8, and 9) are primarily localized intracellularly in the vesicular system. 5 However, surface localization of these TLRs in some cell types may serve to facilitate cell-type-specific immune responses. [6] [7] [8] We recently discovered that RBCs express surface TLR9 and bind CpG containing DNA, driving anemia and innate immune activation during inflammatory states; however, whether other TLRs are expressed on RBCs is unknown. 1, 9 Cell-free RNA (cfRNA), including microRNA, long non-coding RNA, tRNA, or fragments of mRNA, are present in circulation, often encased in vesicles. [10] [11] [12] [13] [14] Although RNA is present throughout RBC development, mature RBCs are presumed to be devoid of RNA. Here we report that human RBCs are a reservoir of RNA, express the RNA sensor TLR7, and bind exogenous viral RNA.

Because we have previously identified the nucleic-acid sensing pattern recognition receptor (PRR) toll-like receptor 9 on erythrocytes and Tlr7 is expressed in erythroid precursors, we asked if TLR7 would be present on RBCs. 15 TLR7 is expressed on purified RBCs (Fig. 1A) .

To ensure that the RBC preparation was devoid of platelets, which also expressed TLR7 and TLR9, 16,17 we performed qRT-PCR for the platelet marker Itga2b (CD41) (Fig. 1B) . We did not detect CD41 in our purified RBC samples, indicating that our RBC samples are free of platelet contamination. We detected TLR7 expression on RBCs from healthy donors and septic adult and pediatric patients with acute respiratory distress syndrome (ARDS) (Fig. 1C-D) . We confirmed our observation using confocal microscopy and two distinct clones of antibodies against TLR7 (Fig. 1E) . We next examined the interaction of TLR7 with the integral membrane protein Band 3 by proximity ligation assay (PLA) to confirm membrane localization of red cell TLR7 ( Fig. 2A-B ). We found close interaction between TLR7 and Band 3, using two distinct antibody combinations ( Fig. 2A and C) . Because we previously found that TLR9 and Band 3 interact in the RBC membrane, we asked if TLR7 interacts with TLR9. 1, 9 TLR7 interacts with TLR9 and Band 3 on the RBC membrane (Fig. 2D) . Collectively, these data establish the presence of the RNA-sensing pattern recognition receptor TLR7 on RBCs and suggests the presence of an immune sensing complex on the RBC membrane.

We previously observed increased TLR9 expression on human RBCs during sepsis compared with healthy donors. However, in contrast to our observations for TLR9, we did not detect increased TLR7 on septic RBCs (Fig. 1D) . Because we observed Band 3-TLR7 interactions, and Band 3 alterations are reported during inflammatory states, including sepsis and malaria, we asked whether Band 3-TLR7 interactions would be altered during sepsis and COVID-19 associated sepsis. 18-20 While TLR7-Band 3 interactions in RBCs from healthy donors were detected by distinct PLA punctae, RBCs from septic patients demonstrated a robust PLA signal with large punctae and aggregates of PLA punctae observed in bacterial sepsis and viral sepsis due to SARS-CoV-2 infection ( Fig. 2A-B) . Because COVID-19 is associated with multisystem inflammatory syndrome (MIS-C), we also evaluated RBCs from two MIS-C patients, who were negative for active infection. We did not observe enhanced TLR7-Band3 interaction in the MIS-C patients. Thus, TLR7 association with RBC membrane proteins is increased during sepsis.

Because we detected TLR7 on RBCs, we examined whether RNA was present on RBCs under basal conditions. Using an RNA-selective dye, we measured the presence of RNA on RBCs (Fig. S1A-B) . Ribosomal RNA has previously been reported in RBCs. 21 We, therefore, quantified 18S rRNA in RBCs from healthy donors and patients with sepsis; buffy coat preparations were used as a positive control. (Fig. S1C-D) . We next asked whether RBCs bind exogenous RNA. We found dose-dependent binding of single-stranded RNA oligoribonucleotide (ORN, RNA40) derived from the HIV-1 sequence (Fig. 3A-B) . 22 Because the acquisition of DNA by RBCs led to morphological changes to the RBCs and masking of the anti-phagocytic epitope of CD47, we asked whether RNA binding would elicit the same response. RNA treatment of RBCs did not result in masking the CD47 anti-phagocytic epitope, suggesting that RBCs can distinguish RNA and DNA (Fig. S2) .

We next asked whether RBCs also acquire pathogen-derived RNA during infection (Fig.   S3A ). Because influenza virus binds directly to red blood cells, we first asked whether viral RNA would be detectable on RBCs following incubation with influenza virus (strain A/Puerto Rico/8/1934 H1N1). 23 Influenza virus RNA is detectable in RBCs following incubation with naïve RBCs (Fig. 3C) , indicating that RBCs acquire viral RNA following binding to virions.

Zika Virus (ZIKV) is a mosquito-borne flavivirus that causes an acute febrile illness in adults and may persist in the circulation weeks after infection. 24 It has recently been reported that ZIKV is detected primarily in the RBC fraction of transfusates, yet it is not known if ZIKV directly binds to RBCs or infects erythroid precursors. 25 We found that naive RBCs bind ZIKV (Fig. 3D) .

We next asked whether RBCs acquire viral RNA by directly binding to RNA; we incubated RBCs with RNA extracted from influenza A virions, Zika virions, or SARS-CoV-2-infected cells ( Fig. 3E-G, S3C-E) . Although we observed heterogeneity in the ability of human RBCs to sequester viral RNA, viral RNA adhered to RBCs, suggesting that RBCs are capable of directly binding RNA from viruses.

Given recent reports of direct infection of erythroid progenitors with SARS-CoV-2 and our own findings of RBC-bound SARS-CoV-2 spike protein, we evaluated RBCs from patients hospitalized with COVID-19 (Fig. 3H) . 26, 27 We did not detect SARS-CoV-2 on RBCs from patients with COVID-19, although this is not surprising given that the day of blood sampling was on average ten days following symptom onset, and few papers have reported viremia in this population. 28, 29 We next asked whether blockade of ligand binding with TLR7-Fc or inhibitory ODNs would attenuate ssRNA acquisition by RBCs. RNA40 binding to RBCs was examined in the presence of increasing doses of soluble recombinant human TLR7-Fc. TLR7-Fc inhibits RNA40 binding in a dose-dependent manner, indicating that RNA40 is a substrate for TLR7 (Fig. 4A-B ).

TLR7 is activated by polyuridine; 22 we therefore tested if RBCs also bind to polyuridine ORN (15-mer ORN, polyU 15 ). We found dose-dependent binding of polyU 15 by RBCs; in addition, polyU 15 competes with RNA40 for RBC binding (Fig. 4C-D) . We then asked if inhibitory oligonucleotides against TLR7 could inhibit RNA binding by RBC. ODN2088 and ODN20959

are CpG-containing oligonucleotides that inhibit TLR7 and TLR9 response in human and murine myeloid cells, whereas ODN105870 is derived from ODN20959 but contains a modified guanine that renders it inhibitory to TLR7 but not TLR9. 30, 31 We observed a dose-dependent inhibition of RNA40 binding by RBC by ODN2088 (Fig. 4E-F) and donor dependent heterogeneity in the inhibition of RNA binding by ODN2088. Similarly, donor heterogeneity was observed with ODN20959 and ODN105870 (Fig. S4) . We verified the ability of inhibitory ODNs to attenuate viral RNA acquisition by RBCs using viral RNA from ZIKV and SARS-CoV-2 ( Fig. 4G-H) .

Collectively these data suggest that synthetic and pathogen derived ssRNA binding to RBCs can be attenuated in the presence of TLR7 and TLR9 ligands.

We demonstrate that TLR7 is expressed on RBCs and observe RNA binding by RBCs, which can be inhibited by TLR7 and 9 inhibitors. While these ODNs inhibit various endosomal TLRs responses, their binding activities are unclear. For example, ODN2088 competes with CpG-containing DNA for the C-terminus of TLR9 and inhibits downstream signaling , but how ODN2088 and other ODNs interact with TLR7 remains elusive. 32 It is plausible that some of these ODNs only inhibit the downstream signaling but not the binding of TLR cognate substrates.

Because TLR7 and TLR9 are in close proximity on the RBC, it is also possible that ODN binding to TLR9 results in conformational changes that reduce the accessibility of ssRNA to TLR7. Further studies to examine this potential are underway. Moreover, it is unknown whether TLR7 expressed on RBCs retains its preference for GU-rich RNA. RBCs may also express alternative receptors for RNA, and it is known that RBCs express the purinergic receptors P2X7 and P2Y1. 33 The reciprocal association of TLR7, TLR9, and Band 3 suggest a potential immune receptor complex on the RBC surface. 5 Band 3 is an anion channel expressed on the RBC surface that adopts multiple topologies and forms various multi-protein macro complexes to maintain optimal RBC structure and function. Clustering proteins of similar function in close proximity is reminiscent of lipid raft where molecules of related functions are concentrated to facilitate efficient signaling and regulation. In-depth investigation on the role of RBC TLR7 and its interacting partners is needed to establish the existence of such an immune sensing complex on the RBC membrane.

In our experiments, fixation and detergent treatment were needed for epitope accessibility of both TLR7 antibodies (4G6 and PA1-10826) that are raised against the TLR7 ectodomain; however, the proximal interactions of TLR7 and Band3 and susceptibility of RNA binding to TLR7 inhibitory oligonucleotides suggest TLR7 is localized on the RBC plasma membrane.

Because the topology of Band 3 changes as RBCs age and during inflammatory conditions, it will be important to determine if TLR7 adopts non-canonical topology on the RBC membrane or if our findings are simply due to epitope accessibility.

Dating back to the HIV pandemic, transfusion-associated viral infection has long been a concern in blood banking. The advent of molecular screening and nucleic acid amplification techniques has dramatically reduced the risk of viral infection following blood transfusion. 34 However, one lingering question has been the persistence of the virus in transfusates. Zika and WNV have both been reported to associate with RBCs in transfusates. West Nile virus (WNV) particles can be associated with RBCs, 35 and persistent of RBC-associated ZIKV RNA has been reported in asymptomatic patients, 36 yet whether the virus directly binds RBCs remained unknown. Consistent with previous reports, we observe the RBC binding of pathogenic viruses and RNA derived from them. Nucleic acids trapped in RBCs are reportedly nuclease resistant. 37 This raises the question of whether RBC-associated RNA is protected from degradation by plasma RNases and is therefore detected following extensive storage even the host or donor no longer harbors the infectious virus. Because RBC-associated WNV retains infectivity, it is plausible that RBC-bound virions are shielded from the host immune response, although in vivo studies will be required to validate this hypothesis.

The ability of RBCs to capture exogenous RNA suggests that RBCs can serve as a reservoir for RNA in the circulation and may be exploited to develop diagnostics for infectious disease, cancer, or other inflammatory states where cell-free RNA may be abundant but not readily detectable in plasma samples. RBCs are associated with multiple types of RNA molecules, including miRNA and ncRNA, 38, 39 but the localization of these molecules is not well defined except the 7SL ncRNA, which is associated with cytoskeletal and membrane proteins in RBCs. Additionally, the function of these RNA molecules in the mature erythrocytes remains elusive. Our findings add to the growing literature demonstrating RNA association with RBCs.

Collectively, our data demonstrate that RBCs bind RNA and express the immune receptor TLR7. RBC-associated RNA may be valuable in disease diagnostics and monitoring.

The discovery of immune receptors on RBCs suggests that RBCs possess unexplored immune function. Future work examining the characteristics of RBC-associated RNA during inflammation and the role of immune receptor expression on RBCs will address our knowledge gap on the long-overlooked non-gas exchanging immune function of RBCs. 

To separate blood fractions, blood samples were centrifuged at 3000 g for 10 min

utes. Plasma and buffy coat were saved or aspirated depending on the experiment. Red blood cells were purified from the remaining packed red cell fraction using magnetic-assisted cell sorting (MACS) or leukoreduction filters as previously described. 1 Afterwards, cells were washed with PBS three times prior to analysis by flow cytometer (BD Fortessa).

Previously frozen RBCs were thawed on ice. RNA was extracted using RNeasy Plus Kit (Qiagen) according to manufacture's protocol. At the initial step, RBCs were lysed in 600μL lysis buffer and at the final step, RNA were eluted in 30μL

RNase-free water. 8μL of freshly isolated RNA were reverse transcribed to cDNA using Superscript First Strand Synthesis system (ThermoFisher) following manufacture's protocol.

qRT-PCR Quantitative RT-PCR was performed using the QuantStudio7 Flex system (Applied Biosystems) with 384 well plates. The amount of cDNA was quantified using PowerUp SYBR or Fast Taqman master mix following manufacturer's protocol. The primers or Taqman assay mix were listed in Supplemental table 2. For quality controls, the resulting amplicons were resolved on 1.2% agarose gel in TBE buffer whenever necessary. Alternatively, for SYBR greenbased assays, melting temperature was compared to controls. 

DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia

Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin

Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells

Pneumococcal immune adherence to human erythrocytes

Regulation of the nucleic acidsensing Toll-like receptors

Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases

Activation of cell membrane-localized Toll-like receptor 3 by siRNA

Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness

Red Blood Cells Homeostatically Bind Mitochondrial DNA through TLR9 to Maintain Quiescence and to Prevent Lung Injury

Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application

Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders

Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing

A comprehensive characterization of the cell-free transcriptome reveals tissue-and subtype-specific biomarkers for cancer detection

RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions

Guanine Modification of Inhibitory Oligonucleotides Potentiates Their Suppressive Function

Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7-and TLR9-Mediated Immune Responses of Human Immune Cells

Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9

P2X and P2Y receptor signaling in red blood cells

Prevention of transfusion-transmitted infections

West Nile Virus Adheres to Human Red Blood Cells in Whole Blood

Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study

Loading of Human Red Blood Cells with DNA and RNA

A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes

Gene expression analysis of human red blood cells

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Plasma angiopoietin-2 as a potential causal marker in sepsisassociated ARDS development: evidence from Mendelian randomization and mediation analysis

Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design

Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis

The research was supported by the NIH grant R01 HL126788 to N.S.M. .